Imgn Stock: Immunogen Has No Immediate Encore After Todays Triumph | Latest News RSS feed

Imgn Stock: Immunogen Has No Immediate Encore After Todays Triumph - Latest News


IMGN Stock: Immunogen Has No Immediate Encore After Today’s Triumph

but presumably the drug had no measurable meaningful benefit. Still, the results were encouraging enough to lead Immunogen to believe it would be able to start phase 2 testing of the drug later this ... read more

Making Sense of the Q1 Earnings Reports

But with a representative-enough sample of earnings reports already out, we have a good sense of how this reporting cycle has unfolded. The trend thus far from the 132 S&P 500 members that have ... read more

Report confirms Brexit's boomerang logic on data protection

The UK will likely have to continue mirroring EU data protection rules encore ... i.e. after it's left the room where those rules are made and debated. Such is the boomerang logic of the Brexit vote ... read more

Looking for another news?


Earnings Growth Finally Turns Positive

The Q3 earnings season is on track to be the first quarter to show positive earnings growth after 5 quarters of back-to-back declines ... But as indicated at the top, growth in Q3 has turned positive ... read more


Q4 Earnings Season Spotlights Growth Challenges

Decent reports from some of the large banks notwithstanding, the overall tone emerging from the results that we have seen already shows no improvement from the weak trend that has been in place for ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us